GO ID |
Ontology |
GO Term |
Term Definition |
Proteins |
GO:0007206
|
BP
|
phospholipase C-activating G-protein coupled glutamate receptor signaling pathway
|
The series of molecular signals generated as a consequence of a G-protein coupled glutamate receptor binding to its physiological ligand, where the pathway proceeds with activation of phospholipase C (PLC) and a subsequent release of inositol trisphosphate (IP3) and diacylglycerol (DAG).
|
HOMER1
|
GO:0007207
|
BP
|
phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway
|
The series of molecular signals generated as a consequence of a G-protein coupled acetylcholine receptor binding to its physiological ligand, where the pathway proceeds with activation of phospholipase C (PLC) and a subsequent release of inositol trisphosphate (IP3) and diacylglycerol (DAG).
|
CHRM2,
CHRM3,
HRH3
|
GO:0007208
|
BP
|
phospholipase C-activating serotonin receptor signaling pathway
|
The series of molecular signals generated as a consequence of a serotonin receptor binding to its physiological ligand, where the pathway proceeds with activation of phospholipase C (PLC) and a subsequent release of inositol trisphosphate (IP3) and diacylglycerol (DAG).
|
HTR2C
|
GO:0007210
|
BP
|
serotonin receptor signaling pathway
|
The series of molecular signals generated as a consequence of a serotonin receptor binding to one of its physiological ligands.
|
HTR2C,
HTR2B
|
GO:0007212
|
BP
|
dopamine receptor signaling pathway
|
The series of molecular signals generated as a consequence of a dopamine receptor binding to one of its physiological ligands.
|
GNAI3,
NSG1,
GSK3B
|
GO:0007213
|
BP
|
G-protein coupled acetylcholine receptor signaling pathway
|
Any series of molecular signals initiated by an acetylcholine receptor on the surface of the target cell binding to one of its physiological ligands, and proceeding with the activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction and ends with regulation of a downstream cellular process, e.g. transcription.
|
RGS10,
GNAI2,
CHRM2,
CHRM3,
GNA11,
GNAQ,
GNB1,
PLCB1
|
GO:0007214
|
BP
|
gamma-aminobutyric acid signaling pathway
|
The series of molecular signals generated by the binding of gamma-aminobutyric acid (GABA, 4-aminobutyrate), an amino acid which acts as a neurotransmitter in some organisms, to a cell surface receptor.
|
GABBR2,
GNAI2,
ATF4,
GABRA5,
SLC12A2,
PLCL1,
GABBR1,
PLCL2
|
GO:0007215
|
BP
|
glutamate receptor signaling pathway
|
A series of molecular signals initiated by the binding of glutamate to a glutamate receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
SSTR1,
GRIA4,
GNAQ,
FMR1,
GRIN2A,
PLCB1
|
GO:0007216
|
BP
|
G-protein coupled glutamate receptor signaling pathway
|
A series of molecular signals initiated by glutamate binding to a glutamate receptor on the surface of the target cell, and proceeding with the activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. Ends with regulation of a downstream cellular process, e.g. transcription.
|
GRM6,
HOMER3
|
GO:0007217
|
BP
|
tachykinin receptor signaling pathway
|
The series of molecular signals generated as a consequence of a tachykinin, i.e. a short peptide with the terminal sequence (Phe-X-Gly-Leu-Met-NH2), binding to a cell surface receptor.
|
GRK5
|
GO:0007218
|
BP
|
neuropeptide signaling pathway
|
The series of molecular signals generated as a consequence of a peptide neurotransmitter binding to a cell surface receptor.
|
AGRP,
CRCP,
NXPH3,
ECEL1,
POMC,
PENK,
SCG5,
NMB,
CPE,
GAL,
NPY1R,
SSTR1,
OPRL1,
NPBWR1,
GLRB,
NMU,
NPY2R,
MC2R,
NPY5R,
CARTPT,
NPB,
KISS1R
|
GO:0007219
|
BP
|
Notch signaling pathway
|
A series of molecular signals initiated by the binding of an extracellular ligand to the receptor Notch on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
NEURL1B,
ADAM10,
ITGB1BP1,
SNAI2,
GMDS,
MYC,
TGFB1,
APP,
KRT19,
ANXA4,
UBC,
BMP2,
AGXT,
MDK,
PLN,
TGFBR2,
CDKN1B,
NOTCH1,
SOX9,
PSEN1,
PSEN2,
ASCL1,
CDH6,
RPS27A,
UBA52,
JAG1,
ADAM17,
CDK6,
HHEX,
NOTCH2,
EP300,
CNTN1,
FOXC1,
HES1,
NR0B2,
ZNF423,
NOTCH2NL,
MIB1,
MAML2,
NKAP,
DNER,
APH1B,
CREBBP,
KAT2B,
MIB2,
APH1A,
PERP,
ITCH,
MAML3,
RITA1,
IFT74,
NR1H4,
SPEN,
S1PR3,
CHAC1,
WDR12,
HEYL,
DLL4,
SEL1L,
HEY1
|
GO:0007220
|
BP
|
Notch receptor processing
|
The series of successive proteolytic cleavages of the Notch protein, which result in an active form of the receptor.
|
ADAM10,
PSEN1,
PSEN2,
JAG1,
ADAM17,
DNER,
APH1B,
APH1A,
DLL4
|
GO:0007221
|
BP
|
positive regulation of transcription of Notch receptor target
|
The activation of transcription of specific genes as a result of Notch signaling, mediated by the Notch intracellular domain.
|
NOTCH1,
MAML2,
MAML3,
RBM15
|
GO:0007223
|
BP
|
Wnt signaling pathway, calcium modulating pathway
|
The series of molecular signals initiated by binding of a Wnt protein to a receptor on the surface of the target cell where activated receptors leads to an increase in intracellular calcium and activation of protein kinase C (PKC).
|
MAP3K7,
FZD6,
NFATC1,
CTNNB1,
WNT5A,
CALM2,
GNB1,
PPP3CA,
TNRC6A,
TNRC6C,
AGO4,
PLCB1,
TCF7L2,
NLK,
AGO2,
FZD4,
TNRC6B
|
GO:0007224
|
BP
|
smoothened signaling pathway
|
A series of molecular signals generated as a consequence of activation of the transmembrane protein Smoothened.
|
C21orf2,
GLI2,
GLI3,
TROVE2,
BMP4,
TGFBR2,
NDST1,
EVC,
PTCH1,
HES1,
SEPT2,
STIL,
NSDHL,
TCTN3,
BBS7,
GPC2,
IQUB,
DYRK2,
DISP1,
TCTN2,
PTCHD1,
HHIP,
IFT27,
HIPK2,
CENPJ,
IFT46,
CC2D2A,
B9D1,
HSPB11
|
GO:0007225
|
BP
|
patched ligand maturation
|
The posttranslational modification of members of the Hedgehog family of signaling proteins in order for Hedgehog to exert its biological activity. These modifications include cleavage of its signal sequence, autocatalytic protein cleavage and the attachment of sterol groups.
|
DISP1
|
GO:0007227
|
BP
|
signal transduction downstream of smoothened
|
The series of molecular signals that are initiated by the transmembrane protein Smoothened. In the presence of a Hedgehog signaling molecule, the Patched protein no longer inhibits the activity of Smoothened, and Smoothened signals via the Hedgehog signaling complex to activate downstream components of the Hedgehog signaling pathway.
|
IFT122
|
GO:0007229
|
BP
|
integrin-mediated signaling pathway
|
A series of molecular signals initiated by the binding of extracellular ligand to an integrin on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
ADAM10,
ITGB1BP1,
TYROBP,
SEMA7A,
ITGA10,
COL3A1,
APOA1,
ITGB3,
ITGB2,
ITGB1,
ITGAV,
ITGA5,
FGR,
ITGAM,
VAV1,
ITGB4,
ITGA2,
ITGB5,
ITGAX,
NME2,
ITGA6,
ITGA3,
ITGB8,
CTGF,
MYH9,
ITGAE,
SYK,
PLP1,
DST,
PTK2,
PTPN11,
COL16A1,
CD47,
CDH17,
ILK,
ADAM9,
CUL3,
ITGA9,
NEDD9,
PRKD1,
ZYX,
CCM2,
FUT8,
ADAMTS1,
VAV3,
ITGA11
|
GO:0007231
|
BP
|
osmosensory signaling pathway
|
The series of molecular signals initiated in response to osmotic change.
|
OSR1,
TRPV4
|
GO:0007249
|
BP
|
I-kappaB kinase/NF-kappaB signaling
|
The process in which a signal is passed on to downstream components within the cell through the I-kappaB-kinase (IKK)-dependent activation of NF-kappaB. The cascade begins with activation of a trimeric IKK complex (consisting of catalytic kinase subunits IKKalpha and/or IKKbeta, and the regulatory scaffold protein NEMO) and ends with the regulation of transcription of target genes by NF-kappaB. In a resting state, NF-kappaB dimers are bound to I-kappaB proteins, sequestering NF-kappaB in the cytoplasm. Phosphorylation of I-kappaB targets I-kappaB for ubiquitination and proteasomal degradation, thus releasing the NF-kappaB dimers, which can translocate to the nucleus to bind DNA and regulate transcription.
|
TLR4,
TLR3,
IRAK2,
MAP3K7,
RIPK2,
ROCK2,
BCL10,
TNF,
CD14,
UBC,
NFKB1,
BCL3,
AVPR2,
RPS27A,
UBA52,
RELB,
REL,
BIRC3,
RIPK1,
TRADD,
TAB1,
IRAK1BP1,
TAB3,
ZNF675,
TANK,
AZI2,
NKIRAS1,
HACD3,
NFKBIL1,
TBK1
|
GO:0007250
|
BP
|
activation of NF-kappaB-inducing kinase activity
|
The stimulation of the activity of NF-kappaB-inducing kinase through phosphorylation at specific residues.
|
TLR3,
MAP3K7,
CHI3L1,
IRAK1,
TIRAP,
ZFP91,
COPS8,
CARD10
|
GO:0007252
|
BP
|
I-kappaB phosphorylation
|
The process of introducing a phosphate group into an inhibitor of kappa B (I-kappaB) protein. Phosphorylation of I-kappaB targets I-kappaB for ubiquitination and proteasomal degradation, thus releasing bound NF-kappaB dimers, which can translocate to the nucleus to bind DNA and regulate transcription.
|
TLR4,
TLR3,
MAP3K7,
TLR2,
PRDX4,
ERC1
|
GO:0007253
|
BP
|
cytoplasmic sequestering of NF-kappaB
|
The selective interaction of the transcription factor NF-kappaB with specific molecules in the cytoplasm, thereby inhibiting its translocation into the nucleus.
|
PSMD10,
IL10,
G3BP2,
FAF1
|
GO:0007254
|
BP
|
JNK cascade
|
An intracellular protein kinase cascade containing at least a JNK (a MAPK), a JNKK (a MAPKK) and a JUN3K (a MAP3K). The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell.
|
MAP2K7,
IRAK2,
MAP3K13,
MAP3K7,
RIPK2,
TNF,
UBC,
ADORA2B,
PTGER4,
MAPK8,
MAPK9,
CRKL,
IRAK1,
RPS27A,
UBA52,
GPS2,
MAPK8IP2,
TAB1,
MAP4K3,
MINK1,
TAB3,
TRIB1,
MAP3K5,
DUSP9,
TNFRSF19,
DUSP10
|
GO:0007256
|
BP
|
activation of JNKK activity
|
The initiation of the activity of the inactive enzyme JUN kinase kinase (JNKK) activity. JNKKs are involved in a signaling pathway that is primarily activated by cytokines and exposure to environmental stress.
|
NRK,
TNIK
|
GO:0007257
|
BP
|
activation of JUN kinase activity
|
The initiation of the activity of the inactive enzyme JUN kinase (JNK).
|
MAP2K7,
TNFSF11,
AXIN1,
SPAG9,
ERN1,
CD40LG,
WNT5A,
SYK,
GAB1,
RIPK1,
PKN1,
MLK4,
MAP3K5,
MDFI,
ZAK,
HACD3,
MAPK8IP3,
MAP4K5
|
GO:0007258
|
BP
|
JUN phosphorylation
|
The process of introducing a phosphate group into a JUN protein.
|
MAPK8,
MAPK9,
MAPK8IP1
|
GO:0007259
|
BP
|
JAK-STAT cascade
|
Any process in which STAT proteins (Signal Transducers and Activators of Transcription) and JAK (Janus Activated Kinase) proteins convey a signal to trigger a change in the activity or state of a cell. The JAK-STAT cascade begins with activation of STAT proteins by members of the JAK family of tyrosine kinases, proceeds through dimerization and subsequent nuclear translocation of STAT proteins, and ends with regulation of target gene expression by STAT proteins.
|
SOCS2,
SOCS3,
SOCS6,
SOCS1,
JAK2,
SOCS5,
STAMBP,
GH1,
GHR,
CCL2,
IFNAR1,
STAT3,
STAT5A,
IFNAR2,
STAT5B,
STAT2,
PKD1,
NMI,
PKD2,
CLCF1
|
GO:0007260
|
BP
|
tyrosine phosphorylation of STAT protein
|
The process of introducing a phosphate group to a tyrosine residue of a STAT (Signal Transducer and Activator of Transcription) protein.
|
JAK2,
F2R,
LEP,
JAK3
|
GO:0007262
|
BP
|
STAT protein import into nucleus
|
The directed movement of dimerized STAT (Signal Transducers and Activators of Transcription) proteins into the nucleus following activation by members of the janus activated kinase (JAK) family of tyrosine kinases.
|
JAK2,
F2R,
JAK3,
HES1
|
GO:0007263
|
BP
|
nitric oxide mediated signal transduction
|
Any intracellular signal transduction in which the signal is passed on within the cell via nitric oxide (NO). Includes synthesis of nitric oxide, receptors/sensors for nitric oxide (such as soluble guanylyl cyclase/sGC) and downstream effectors that further transmit the signal within the cell. Nitric oxide transmits its downstream effects through either cyclic GMP (cGMP)-dependent or independent mechanisms.
|
DDAH1,
DDAH2,
AGT,
APOE,
CD36,
FPR1,
NOS3,
NPY2R,
AGTR2,
MT1X,
NDNF,
RASD1
|
GO:0007264
|
BP
|
small GTPase mediated signal transduction
|
Any series of molecular signals in which a small monomeric GTPase relays one or more of the signals.
|
RAB27B,
KRIT1,
ARHGAP33,
RAB29,
SIAH2,
DAB1,
BCAR3,
RHOBTB3,
DIRAS3,
HMOX1,
RAC2,
VAV1,
RHOQ,
ARF4,
RAB3B,
RAB5A,
CHM,
CHML,
TRIM23,
ARL4D,
GDI2,
RAB5C,
RAB7A,
RAB9A,
RAB28,
RAB27A,
RAP1GDS1,
GEM,
RRAD,
RAC3,
CDC42,
RAB4B,
RAB2A,
RAB5B,
RAB11A,
RAB1A,
RAC1,
ARF1,
ARF5,
SOS2,
TNK2,
ARL16,
RAB40B,
ABR,
PLD1,
RAB31,
RAB32,
RAB33A,
RALBP1,
RHEB,
ITSN1,
RAB11B,
ARHGAP31,
RABL6,
RALGPS1,
DOCK11,
RAB12,
KNDC1,
ARHGAP30,
RALGPS2,
ARL17A,
RASEF,
ARHGAP18,
ARL14,
DOCK8,
RHEBL1,
RAB2B,
RIN2,
RAPGEF4,
DOCK2,
RAB8B,
RERG,
ARL8A,
DOCK10,
RASD2,
RAB39B,
DOCK6,
ARL5B,
DOCK7,
RASL10B,
CHP1,
RASL11B,
IFT27,
RAB34,
RAB1B,
DOCK5,
RRAGC,
RAB6B,
ARL8B,
NKIRAS1,
RGL1,
DNAJC27,
HACD3,
VAV3,
RAB21,
RAB22A,
RAB23,
AGAP1,
RASD1,
MFHAS1,
SRPRB,
ARL5A
|
GO:0007265
|
BP
|
Ras protein signal transduction
|
A series of molecular signals within the cell that are mediated by a member of the Ras superfamily of proteins switching to a GTP-bound active state.
|
SDCBP,
NRAS,
KRAS,
TP53,
IGF1,
JUN,
RB1,
FGF2,
RRAS,
RALA,
RALB,
CCNA2,
CDK2,
DNMT1,
CDKN1A,
CRKL,
MAPKAPK2,
RRAS2,
GNB1,
GRB2,
SHC2,
SOS1,
RALGDS,
TRIM28,
G3BP1,
PLD1,
PRKD1,
DHCR24,
MAPK14,
RASGRP2,
IQGAP3,
RAPGEF6,
RIT1,
SYNGAP1,
USP28,
DOK1,
RASSF1,
PLK2,
G3BP2
|
GO:0007266
|
BP
|
Rho protein signal transduction
|
A series of molecular signals within the cell that are mediated by a member of the Rho family of proteins switching to a GTP-bound active state.
|
RHOD,
TAX1BP3,
ARHGAP6,
ROCK2,
PTH,
COL1A2,
CFL1,
AGTR1,
BCL6,
CDH13,
SYNJ2BP,
RHOA,
RHOB,
GNA12,
ARHGAP5,
MYO9B,
ARHGAP29,
PHACTR4,
RHOJ,
ARHGEF3,
HACD3,
CTNNAL1,
CDC42EP3,
ADGRG1
|
GO:0007267
|
BP
|
cell-cell signaling
|
Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions.
|
CYR61,
ADAM10,
NRP1,
EREG,
DHH,
FADS1,
GREM1,
TUSC2,
WISP2,
FGF18,
MPZL1,
WISP1,
CXCL14,
NUDT3,
AGT,
NGF,
GNRH1,
POMC,
CGA,
LHB,
PTH,
GHRH,
INS,
IL1B,
C1QA,
AMH,
PDGFA,
ITGB2,
INHA,
EDN1,
PGR,
S100A9,
ADRB2,
INHBA,
ADRB1,
NMB,
WNT2,
CCL3,
AR,
TXN,
IAPP,
PTHLH,
BMP2,
BMP3,
CCL4,
CCL5,
ADRB3,
AREG,
GJA1,
ADRA2B,
CD33,
TRH,
IL11,
EFNA1,
FGFR2,
IL10,
BDNF,
ADRA1D,
PCSK1,
CTGF,
ADORA1,
SSTR1,
SRD5A2,
FGF9,
ADM,
ADRA1A,
ADRA1B,
CXCL5,
GDF5,
NAMPT,
GATA4,
CD97,
PGF,
TNFSF10,
INSL3,
EFNA4,
EFNB2,
FGF12,
TGFB2,
GRB2,
CCL20,
CCL8,
CXCL6,
CRB1,
TNFAIP6,
NDP,
TEK,
PCDH1,
BST2,
MERTK,
KLF10,
SEMA3B,
SEMA5A,
IL18,
FAT1,
ZYX,
CARTPT,
CTF1,
FJX1,
CHST4,
ESR2,
PCSK5,
FGF13,
FGF11,
FGF14,
PANX1,
PKP4,
GDF15,
TOLLIP,
ASH1L,
STAB1,
LNPEP,
GUCA1B,
ADGRG1,
TNFRSF11A
|
GO:0007268
|
BP
|
chemical synaptic transmission
|
The vesicular release of classical neurotransmitter molecules from a neuron, across a chemical synapse, the subsequent activation of neurotransmitter receptors of a target cell (neuron, muscle, or secretory cell) and the effects of this activation on the postsynaptic membrane potential and ionic composition of the postsynaptic cytosol. This process encompasses both spontaneous and evoked release of neurotransmitter and all parts of synaptic vesicle exocytosis. Evoked transmission starts with the arrival of an action potential at the presynapse.
|
SDCBP,
DLGAP1,
KCNK3,
GRM6,
CACNA1G,
LRP6,
GABBR2,
GLS,
PENK,
CNP,
PTPRF,
SYN1,
SYT1,
CBLN1,
PTPRD,
HTR2C,
MAPK1,
SLC6A1,
CHRNA5,
SSTR1,
GABRA5,
HTR7,
CTNNB1,
SSTR5,
GJC1,
OPRL1,
HTR2B,
SLC1A3,
SLC1A2,
NPTX2,
GRIA4,
NPBWR1,
GLRB,
SLC1A6,
NPY2R,
MTNR1B,
PPT1,
NOVA1,
ATXN3,
CACNB3,
PLP1,
SNAP25,
FGF12,
DLG4,
CDK5,
PMP22,
APBA1,
SLC18A2,
KCNA1,
GRIN2A,
DLG1,
UNC119,
GPR176,
GRM3,
NPY5R,
CACNA1E,
ASIC2,
CARTPT,
HOMER1,
MINK1,
SYN2,
CEP89,
PDE7B,
KCNIP2,
NRXN1,
MYO5A,
DTNA,
PCDHB9,
PCDHB3,
PCDHB14
|
GO:0007269
|
BP
|
neurotransmitter secretion
|
The regulated release of neurotransmitter from the presynapse into the synaptic cleft via calcium regualated exocytosis during synaptic transmission.
|
CASK,
SNAPIN,
SYN1,
SYT1,
PPT1,
SNAP25,
STXBP1,
VAMP2,
APBA1,
SLC18A2,
PDZD11,
SYN2,
LIN7B,
LIN7C,
NRXN1,
HRH3
|
GO:0007270
|
BP
|
neuron-neuron synaptic transmission
|
The process of communication from a neuron to another neuron across a synapse.
|
KIF1B,
DRD2,
PTEN
|
GO:0007271
|
BP
|
synaptic transmission, cholinergic
|
The process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse using the neurotransmitter acetylcholine.
|
APOE,
CHRM2,
CHRNB1,
NQO1,
CHRM3,
CHRNA5,
CHRNA7,
LYPD1,
HRH3
|
GO:0007274
|
BP
|
neuromuscular synaptic transmission
|
The process of communication from a neuron to a muscle, across a synapse.
|
KIF1B,
FCHSD2,
CHRNB1,
CHRNA5,
ETV5,
STXBP1,
EGR3,
DTNA
|
GO:0007275
|
BP
|
multicellular organism development
|
The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult).
|
CNOT1,
WIPF3,
HACD1,
ENC1,
TNFRSF10C,
MUSK,
HMGB3,
EDIL3,
EDF1,
DIAPH2,
MITF,
GADD45B,
CREG1,
RECQL4,
WDR47,
GADD45G,
ZBTB7A,
EYA4,
ZMYM6,
CLPTM1,
F2,
GNRH1,
IGF2,
TP53,
CSF1R,
ZFY,
PAEP,
BMP1,
VCAN,
LIF,
HIVEP1,
ZFX,
TNFRSF1B,
MAK,
RPS4Y1,
MMP11,
ADRA1D,
LMO2,
TNFRSF8,
GNRHR,
HOXA10,
HIVEP2,
ADRA1B,
LTBR,
SERPINF1,
GPX4,
LEPR,
HOXA1,
MEOX1,
PLXNA3,
ARHGDIB,
AGFG1,
HMGA2,
EMP1,
KLF3,
TPI1,
DCAF7,
ELF3,
DAB2,
CENPE,
ID2,
ID3,
CREM,
NOTCH2,
TLE1,
CD164,
MXD1,
MCL1,
AES,
MN1,
BST2,
CUX1,
CDK13,
ZMYM3,
DIP2A,
PSME4,
PCOLCE,
ELAVL1,
CSRP2,
HLF,
QRICH1,
ODF2,
HIVEP3,
SFRP5,
TMEM198,
SFRP4,
DPY19L2,
SHISA2,
LCLAT1,
SLCO4C1,
TSHZ1,
NOTCH2NL,
PIWIL4,
SPRED1,
ZSCAN2,
SPATA24,
C19orf68,
ERC1,
TMEFF1,
GCNT2,
MTURN,
MINK1,
BANP,
TRIML1,
LSM14A,
TDRD9,
PHC3,
SPATA20,
SLC2A14,
FAT3,
PAQR8,
CHURC1,
EDARADD,
FAM3C,
TNFRSF25,
PTP4A1,
PBXIP1,
CREB3L1,
KAZALD1,
GMCL1,
ST6GAL2,
ZFR,
STRBP,
MNT,
APOL2,
SPATA9,
SPRY4,
PDGFD,
PDLIM7,
TSHZ2,
OLFML3,
DUSP22,
HELLS,
MBNL3,
ASF1B,
PAQR5,
DONSON,
FMN2,
EHF,
GRHL1,
DSPP,
ADAMTS9,
THEG,
DKK2,
ZMYM2,
CFDP1,
PLEKHB1,
DMBT1,
LIMD1,
DACH1,
PLXNA1,
ZMYM5,
TUBD1,
OSGIN1,
TCFL5,
SUFU,
PRELID1,
INVS,
DRG1,
CHST2,
RNF114,
WIF1,
SPIN1,
POMT1
|
GO:0007276
|
BP
|
gamete generation
|
The generation and maintenance of gametes in a multicellular organism. A gamete is a haploid reproductive cell.
|
CTDNEP1,
WNT3,
SMAD1,
SPIN4,
FANCD2,
ZNF148,
SPIN1
|
GO:0007281
|
BP
|
germ cell development
|
The process whose specific outcome is the progression of an immature germ cell over time, from its formation to the mature structure (gamete). A germ cell is any reproductive cell in a multicellular organism.
|
ANGPT2,
BMP4,
WT1,
AKT1,
MSH2,
ACVR1,
BAX,
SMAD5,
LIN28A
|
GO:0007283
|
BP
|
spermatogenesis
|
The process of formation of spermatozoa, including spermatocytogenesis and spermiogenesis.
|
MEIOC,
WIPF3,
ARNTL,
RAD51C,
BCL2L11,
SPAG9,
KHDRBS3,
CRTAP,
SBF1,
PTTG1,
APOB,
SLC4A2,
SERPINA5,
ERCC1,
AR,
KIT,
IGF2R,
SKIL,
ACE,
CCNB1,
H2AFX,
MAK,
CNR1,
ATP2B4,
FSHR,
BRD2,
YY1,
ACVR2A,
CALR,
KDM5A,
CDC25C,
SSTR1,
HOXA10,
DNAJA1,
KRT9,
NUP62,
MLH1,
BCL6,
RGS2,
ADCYAP1R1,
ATRX,
NOTCH1,
SOX9,
INSL3,
BCAP31,
BRCA2,
NR0B1,
LIMK2,
PRKAG1,
RAD23B,
SOX8,
BTG1,
UBE2B,
PAFAH1B2,
CCNA1,
CDK16,
HSF1,
E2F1,
HIST1H1A,
CREM,
TYRO3,
MERTK,
PRDX4,
SMAD4,
BIRC3,
CCNI,
FAM50A,
WFDC2,
PUM1,
ACOX1,
PAFAH1B3,
RGN,
SPA17,
TESK1,
TRIP13,
ARID4B,
MORN2,
HERC4,
ALKBH5,
SLCO4C1,
SETX,
PIWIL4,
ZSCAN2,
SPATA24,
TDRP,
SIAH1,
ASPM,
TDRD9,
MNS1,
WDR48,
SPATA20,
KIAA1524,
SLC2A14,
IFT81,
BCL2L2,
BAD,
TMEM203,
RPL39L,
DAZAP1,
GMCL1,
MYCBP,
PAIP2,
HERPUD2,
NDC1,
KIFC1,
SPATA9,
LGR4,
TEX15,
CADM1,
EIF5A2,
RACGAP1,
SOX17,
USP42,
PATZ1,
SPAG4,
PARP11,
CYP26B1,
DIAPH3,
ASF1B,
DNAH9,
THEG,
DUSP13,
TUBD1,
TCFL5,
CDYL,
RUVBL1,
RNF114,
PCYT1B
|
GO:0007286
|
BP
|
spermatid development
|
The process whose specific outcome is the progression of a spermatid over time, from its formation to the mature structure.
|
FANCG,
DHH,
RNF8,
KIT,
RFX2,
SMARCA2,
H3F3A,
NSUN2,
TRIP13,
STK11,
ODF2,
DPY19L2,
CEP57,
RSPH1,
PACRG,
QKI,
STRBP,
CIB1,
JAM3,
PANK2,
SLIRP,
IQCG,
MKKS,
NECTIN3,
AFF4
|
GO:0007288
|
BP
|
sperm axoneme assembly
|
The assembly and organization of the sperm flagellar axoneme, the bundle of microtubules and associated proteins that forms the core of the eukaryotic sperm flagellum, and is responsible for movement.
|
UBE2B,
BBS2,
IQCG
|
GO:0007289
|
BP
|
spermatid nucleus differentiation
|
The specialization of the spermatid nucleus during the development of a spermatid into a mature male gamete competent for fertilization.
|
HMGB2,
AGFG1,
TMF1,
PYGO2,
GOPC
|
GO:0007292
|
BP
|
female gamete generation
|
Generation of the female gamete; specialised haploid cells produced by meiosis and along with a male gamete takes part in sexual reproduction.
|
GDF9,
DIAPH2,
PARN,
BMP15,
FSHB,
FSHR,
DYNLL1,
TOB2,
MCM8
|
GO:0007296
|
BP
|
vitellogenesis
|
The production of yolk. Yolk is a mixture of materials used for embryonic nutrition.
|
FOSL1,
SOS1,
ZMIZ1
|
GO:0007338
|
BP
|
single fertilization
|
The union of male and female gametes to form a zygote.
|
UBXN8,
DNALI1,
CLGN,
ADCY3,
AR,
CD46,
HOXD10,
HOXA10,
GNPDA1,
FOXL2,
H3F3A,
MFGE8,
LRMP,
SMAD4,
TRPC3,
SPA17,
WDR48,
TUBGCP3,
SLIRP,
KDM5B,
FETUB,
ADAM21,
TRPC6
|
GO:0007339
|
BP
|
binding of sperm to zona pellucida
|
The process in which the sperm binds to the zona pellucida glycoprotein layer of the egg. The process begins with the attachment of the sperm plasma membrane to the zona pellucida and includes attachment of the acrosome inner membrane to the zona pellucida after the acrosomal reaction takes place.
|
CLGN,
B4GALT1,
TCP1,
ZP3,
SPAM1,
CCT3,
CCT8,
ZP1,
CCT2,
SPA17,
CCT7,
FETUB,
ADAM21
|
GO:0007340
|
BP
|
acrosome reaction
|
The discharge, by sperm, of a single, anterior secretory granule following the sperm's attachment to the zona pellucida surrounding the oocyte. The process begins with the fusion of the outer acrosomal membrane with the sperm plasma membrane and ends with the exocytosis of the acrosomal contents into the egg.
|
ADCY3,
STX2,
GLRB
|
GO:0007341
|
BP
|
penetration of zona pellucida
|
The infiltration by sperm of the zona pellucida to reach the oocyte. The process involves digestive enzymes from a modified lysosome called the acrosome, situated at the head of the sperm.
|
B4GALT1
|
GO:0007342
|
BP
|
fusion of sperm to egg plasma membrane
|
The binding and fusion of a sperm, having penetrated the zona pellucida, with the plasma membrane of the oocyte. Binding occurs at the posterior (post-acrosomal) region of the sperm head.
|
SERPINA5,
CD9,
SPAM1
|
GO:0007344
|
BP
|
pronuclear fusion
|
The merging of two pronuclei in a fertilized egg to fuse and produce a single zygotic genome.
|
CDK1
|
GO:0007346
|
BP
|
regulation of mitotic cell cycle
|
Any process that modulates the rate or extent of progress through the mitotic cell cycle.
|
SDCBP,
DAPK3,
CDC123,
RB1,
CKS2,
RPA3,
CDKN1C,
ASCL1,
PLK1,
SIK1,
CKS1B,
PTCH1,
ZNF268,
MAEA,
AFAP1L2,
NEK7,
GBF1,
NEK6,
CYLD,
RPRM,
THAP1,
AATF,
SAE1,
FBXO5
|
GO:0007352
|
BP
|
zygotic specification of dorsal/ventral axis
|
The specification of the dorsal/ventral axis of the embryo, through the products of genes expressed in the zygote.
|
SMAD6,
SMAD2
|
GO:0007354
|
BP
|
zygotic determination of anterior/posterior axis, embryo
|
The specification of the anterior/posterior axis of the embryo by products of genes expressed in the zygote; exemplified in insects by the gap genes, pair rule genes and segment polarity gene cascade.
|
PCSK6
|
GO:0007356
|
BP
|
thorax and anterior abdomen determination
|
Specification of the central (trunk) regions of the embryo by the gap genes; exemplified in insects by the actions of the Kruppel gene product.
|
WT1
|
GO:0007368
|
BP
|
determination of left/right symmetry
|
The establishment of an organism's body plan or part of an organism with respect to the left and right halves. The pattern can either be symmetric, such that the halves are mirror images, or asymmetric where the pattern deviates from this symmetry.
|
AXIN1,
TBX1,
PSKH1,
ACVR2A,
PCSK6,
NOTCH1,
ACVR1,
AP1B1,
PKD2,
ACVR2B,
STIL,
ARMC4,
NPHP3,
NEK8,
BBS7,
DYNC2LI1,
DNAH5,
PCSK5,
DNAH11,
DISP1,
IFT74,
DRC1,
PITX2,
CITED2,
BICC1,
MKKS,
MKS1,
CC2D2A,
DNAI1
|
GO:0007369
|
BP
|
gastrulation
|
A complex and coordinated series of cellular movements that occurs at the end of cleavage during embryonic development of most animals. The details of gastrulation vary from species to species, but usually result in the formation of the three primary germ layers, ectoderm, mesoderm and endoderm.
|
DLD,
TGFBR2,
HIRA,
RPS6,
RACK1,
CUL3,
SMAD2,
EXT1,
NR4A3
|
GO:0007379
|
BP
|
segment specification
|
The process in which segments assume individual identities; exemplified in insects by the actions of the products of the homeotic genes.
|
HOXA2,
MTF2,
MAFB
|
GO:0007386
|
BP
|
compartment pattern specification
|
The regionalization process in which embryonic segments are divided into compartments that will result in differences in cell differentiation.
|
NOTCH1
|
GO:0007389
|
BP
|
pattern specification process
|
Any developmental process that results in the creation of defined areas or spaces within an organism to which cells respond and eventually are instructed to differentiate.
|
MID1,
TBX1,
GLI2,
APC,
ZEB1,
ZIC1,
SOSTDC1,
RNF111,
SHROOM3,
SYNGAP1
|
GO:0007398
|
BP
|
ectoderm development
|
The process whose specific outcome is the progression of the ectoderm over time, from its formation to the mature structure. In animal embryos, the ectoderm is the outer germ layer of the embryo, formed during gastrulation.
|
STX2,
CTNNB1,
NF2,
BMPR1A,
ZBTB17
|
GO:0007399
|
BP
|
nervous system development
|
The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.
|
DPYSL4,
ENC1,
TPP1,
DCLK1,
RBFOX2,
ITM2A,
ZEB2,
GAS7,
SHOX2,
SCRG1,
CSPG5,
GDF11,
FGF19,
FOS,
APOB,
INHA,
CHRM2,
INHBA,
FGF2,
CXCL1,
VEGFA,
NDUFV2,
CHRM3,
MDK,
GAL,
CBLN1,
BDNF,
EPHB2,
ADORA1,
SDHA,
STAT3,
NBL1,
GLRB,
PPT1,
SMARCA2,
SMARCA4,
EFNA5,
ATXN3,
NAGLU,
DLX5,
HDAC4,
PRPS1,
FGF12,
DLG4,
JAG1,
SIM1,
VLDLR,
PURA,
NDP,
SLC7A5,
NRG1,
APBA1,
NOTCH2,
MEF2C,
PCDH1,
EP300,
DLG1,
LSAMP,
GPM6B,
SEMA5A,
ARHGEF7,
SIM2,
DCTN1,
HES1,
ELAVL3,
PPP2R5D,
MEF2D,
PAFAH1B3,
ERBB4,
MPPED2,
DPYSL2,
CTF1,
ZNF423,
TMEM41B,
CPLX2,
GPSM1,
RBM45,
SIAH1,
CNTN4,
CHERP,
NLGN1,
ARID1B,
CSGALNACT1,
PHF10,
GPR98,
MYLIP,
ST8SIA4,
DPF3,
FGF13,
FGF11,
FGF14,
SMARCC1,
SMARCD1,
HES6,
MARK4,
ATOH8,
FEZ1,
MTR,
SIGMAR1,
OLFM1,
PCDHAC1,
SDCBP2,
SEMA6A,
BEX1,
HES4,
NRN1,
MBNL1,
RBFOX1,
STMN3,
CRIM1,
DOK5,
CNTN3,
MBD5,
ATXN10,
EVL,
MYT1L,
INTU,
PCDHA7,
PCDHA6,
PCDHA4,
ARHGAP26,
IGSF9B,
ITM2B,
PCDHB3,
PCDHA8,
PCDHA5,
PCDHA3,
PCDHA2,
PCDHA11,
PCDHA10,
PCDHA1,
PCDHAC2,
MAFB,
BZW2
|
GO:0007400
|
BP
|
neuroblast fate determination
|
The cell fate determination process in which a cell becomes capable of differentiating autonomously into a neuroblast cell regardless of its environment; upon determination, the cell fate cannot be reversed. An example of this process is found in Mus musculus.
|
ASCL1
|
GO:0007403
|
BP
|
glial cell fate determination
|
The cell fate determination process in which a cell becomes capable of differentiating autonomously into a glial cell regardless of its environment; upon determination, the cell fate cannot be reversed.
|
CTNNB1
|
GO:0007405
|
BP
|
neuroblast proliferation
|
The expansion of a neuroblast population by cell division. A neuroblast is any cell that will divide and give rise to a neuron.
|
EML1,
PLXNB2,
ID4,
ASCL1,
KCNA1,
DAGLB,
FRS2,
HHIP,
RACGAP1,
NDE1
|
GO:0007406
|
BP
|
negative regulation of neuroblast proliferation
|
Any process that stops, prevents, or reduces the frequency, rate or extent of the proliferation of neuroblasts.
|
TGFB1,
CTNNA1,
KCTD11
|
GO:0007409
|
BP
|
axonogenesis
|
De novo generation of a long process of a neuron, that carries efferent (outgoing) action potentials from the cell body towards target cells. Refers to the morphogenesis or creation of shape or form of the developing axon.
|
APBB1,
PAK3,
FLOT1,
ECM2,
S100B,
APP,
CCK,
S100A6,
CNP,
BCL2,
NEFH,
DRD2,
STMN1,
OGN,
FGFR2,
CTNNA2,
NOTCH1,
NUMB,
GSK3B,
PTPN11,
FMOD,
ANK3,
PICALM,
STK11,
PLPPR4,
SLITRK4,
CNTN4,
PARD3,
NRCAM,
DOCK7,
ALS2,
EPYC,
PARD6B,
SPTBN4,
SEMA4A,
SPAST
|
GO:0007411
|
BP
|
axon guidance
|
The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues.
|
MATN2,
CHL1,
NRP1,
FLRT2,
SIAH2,
B4GAT1,
KIF5C,
NRP2,
RPS6KA5,
KLF7,
SLIT2,
UNC5C,
NRAS,
KRAS,
NTRK1,
FYN,
CSF1R,
NGFR,
GLI2,
GLI3,
NCAM1,
EZR,
CREB1,
EFNA1,
ANOS1,
BDNF,
LAMA2,
MAPK3,
MAPK1,
EPHB2,
OTX2,
GPC1,
WNT5A,
NKX2-1,
CXCL12,
LHX2,
ETV1,
EFNA4,
EFNB2,
EFNA5,
EPHA5,
EPHB1,
DLX5,
WNT3,
TGFB2,
GRB2,
RAC1,
SPTBN1,
PRKCQ,
PTK2,
SOS1,
ANK3,
SEMA3B,
SMAD4,
TUBB3,
SEMA3A,
NECTIN1,
EXT1,
DPYSL2,
PTPRO,
ZNF280D,
ZNF280B,
SIAH1,
CNTN4,
ENAH,
NR4A3,
TNR,
APBB2,
ROBO3,
RANBP9,
FEZ1,
SEMA3C,
SPON2,
SPTBN4,
SEMA6A,
NTN4,
ROBO2,
B3GNT2,
FLRT3,
EVL,
NRXN1,
MAPK8IP3
|
GO:0007412
|
BP
|
axon target recognition
|
The process in which an axon recognizes and binds to a set of cells with which it may form stable connections.
|
UCHL1,
STXBP1
|
GO:0007413
|
BP
|
axonal fasciculation
|
The collection of axons into a bundle of rods, known as a fascicle.
|
NRP1,
NCAM2,
CNR1,
EPHB2,
SEMA5A,
SEMA3A,
CNTN4,
NRCAM,
CRTAC1,
RTN4,
CELSR3
|
GO:0007416
|
BP
|
synapse assembly
|
The aggregation, arrangement and bonding together of a set of components to form a synapse.
|
RAB29,
GNPAT,
DRD2,
BDNF,
PTEN,
CDK5,
NRG1,
SDK2,
SDK1,
NLGN1,
DNER,
SPOCK2,
NRCAM,
ADGRL3,
FLRT3,
NRXN1,
PLXND1,
FARP1,
PCDHB9,
PCDHB3,
PCDHB14,
PCLO
|
GO:0007417
|
BP
|
central nervous system development
|
The process whose specific outcome is the progression of the central nervous system over time, from its formation to the mature structure. The central nervous system is the core nervous system that serves an integrating and coordinating function. In vertebrates it consists of the brain and spinal cord. In those invertebrates with a central nervous system it typically consists of a brain, cerebral ganglia and a nerve cord.
|
RNF103,
NCAN,
TPP1,
DCLK1,
PARK2,
ADAM23,
VNN1,
S100B,
FYN,
LYN,
GSTP1,
HAPLN1,
VCAN,
ARSB,
TIMP2,
PAM,
MAL,
COX7B,
ACVR1B,
ZEB1,
CSK,
NES,
ALDH3A2,
RCAN1,
ATN1,
PTEN,
ID3,
ZBTB16,
PAX8,
STK4,
ASIC2,
CASZ1,
ANKLE2,
AHI1,
DNER,
NRCAM,
BCAN,
SERPINI1,
NPAS2,
SH3GL2,
B3GNT5,
WWP1,
ELP3,
ROBO2,
PDGFC,
VNN3,
CHD7,
HPCAL4,
JRKL
|
GO:0007418
|
BP
|
ventral midline development
|
The process whose specific outcome is the progression of the ventral midline over time, from its formation to the mature structure. In protostomes (such as insects, snails and worms) as well as deuterostomes (vertebrates), the midline is an embryonic region that functions in patterning of the adjacent nervous tissue. The ventral midline in insects is a cell population extending along the ventral surface of the embryo and is the region from which cells detach to form the ventrally located nerve cords. In vertebrates, the midline is originally located dorsally. During development, it folds inwards and becomes the ventral part of the dorsally located neural tube and is then called the ventral midline, or floor plate.
|
GLI2
|
GO:0007420
|
BP
|
brain development
|
The process whose specific outcome is the progression of the brain over time, from its formation to the mature structure. Brain development begins with patterning events in the neural tube and ends with the mature structure that is the center of thought and emotion. The brain is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight, hearing, smell, etc.).
|
MACROD2,
EML1,
KCNK3,
PLXNB2,
PHGDH,
NDUFS4,
BCL2L11,
TSPAN2,
CTNND1,
TULP3,
CLN5,
UNC5C,
MBD3,
CST3,
APOD,
SCT,
EGR2,
BCR,
XRCC5,
STMN1,
ARF4,
EPOR,
ATP2B1,
S1PR1,
SYT1,
CD9,
PTPRG,
FAS,
MT3,
CD27,
AK4,
SMARCA1,
GABRA5,
TGFBR2,
ID1,
CSK,
NKX2-1,
NES,
STAR,
SEPP1,
AGTR2,
HNMT,
PPT1,
BRCA2,
AFF2,
HRSP12,
FOXG1,
OXCT1,
BID,
ATP6V0D1,
PAFAH1B2,
PRKDC,
H3F3A,
HMGCS1,
PTPN11,
DLX2,
FOXC1,
ABR,
PTCH1,
SHROOM2,
BMPR2,
COX17,
POU6F1,
RAB3GAP1,
PAFAH1B3,
ZFHX3,
ZIC1,
PFKFB3,
NIPBL,
CNTN4,
BBS7,
TMEM57,
PCDH19,
PROX1,
CITED1,
PYGO2,
CADM1,
B3GNT5,
ZNF335,
ROBO2,
CHD8,
PCDH18,
ABCB6,
DDIT4,
SPHK1,
H2AFY2,
CDH22,
NDRG4,
BOK,
SLC7A11,
IRS2,
ADGRG1
|
GO:0007422
|
BP
|
peripheral nervous system development
|
The process whose specific outcome is the progression of the peripheral nervous system over time, from its formation to the mature structure. The peripheral nervous system is one of the two major divisions of the nervous system. Nerves in the PNS connect the central nervous system (CNS) with sensory organs, other organs, muscles, blood vessels and glands.
|
ERBB2,
EGR2,
ERBB3,
ALDH3A2,
SOX8,
PMP22,
NRG1,
EGR3,
ASIC2,
SERPINI1
|
GO:0007423
|
BP
|
sensory organ development
|
The process whose specific outcome is the progression of sensory organs over time, from its formation to the mature structure.
|
MAFB
|
GO:0007431
|
BP
|
salivary gland development
|
The process whose specific outcome is the progression of the salivary gland over time, from its formation to the mature structure. Salivary glands include any of the saliva-secreting exocrine glands of the oral cavity.
|
CST3
|
GO:0007435
|
BP
|
salivary gland morphogenesis
|
The process in which the anatomical structures of the salivary gland are generated and organized.
|
EGFR,
TGFB1,
TGFB2
|
GO:0007440
|
BP
|
foregut morphogenesis
|
The process in which the anatomical structures of the foregut are generated and organized.
|
NOTCH1
|
GO:0007442
|
BP
|
hindgut morphogenesis
|
The process in which the anatomical structures of the hindgut are generated and organized.
|
GLI2,
GLI3,
WNT5A
|
GO:0007492
|
BP
|
endoderm development
|
The process whose specific outcome is the progression of the endoderm over time, from its formation to the mature structure. The endoderm is the innermost germ layer that develops into the gastrointestinal tract, the lungs and associated tissues.
|
TGFB1,
LAMC1,
GATA4,
NKX2-1,
NOTCH1,
SMAD3,
HHEX,
SMAD4,
EXT1,
ARC,
MED12
|
GO:0007493
|
BP
|
endodermal cell fate determination
|
The cell fate determination process in which a cell becomes capable of differentiating autonomously into an endoderm cell regardless of its environment; upon determination, the cell fate cannot be reversed.
|
GATA6,
SOX17
|
GO:0007494
|
BP
|
midgut development
|
The process whose specific outcome is the progression of the midgut over time, from its formation to the mature structure. The midgut is the middle part of the alimentary canal from the stomach, or entrance of the bile duct, to, or including, the large intestine.
|
DAB1,
ALDH1A2,
EGFR,
ASS1,
WNT5A
|
GO:0007498
|
BP
|
mesoderm development
|
The process whose specific outcome is the progression of the mesoderm over time, from its formation to the mature structure. The mesoderm is the middle germ layer that develops into muscle, bone, cartilage, blood and connective tissue.
|
TBX1,
JAK2,
GDF11,
CTDNEP1,
ETS2,
VEGFA,
ACVR2A,
TIE1,
LHX2,
IRX3,
TCF15,
IKZF1,
SMAD4,
ACVR2B,
EXT1,
MEST,
SECTM1
|
GO:0007500
|
BP
|
mesodermal cell fate determination
|
The cell fate determination process in which a cell becomes capable of differentiating autonomously into a mesoderm cell regardless of its environment; upon determination, the cell fate cannot be reversed.
|
KLF4,
BMP4
|
GO:0007501
|
BP
|
mesodermal cell fate specification
|
The cell fate determination process in which a cell becomes capable of differentiating autonomously into a mesoderm cell in an environment that is neutral with respect to the developmental pathway; upon specification, the cell fate can be reversed.
|
EYA2
|
GO:0007506
|
BP
|
gonadal mesoderm development
|
The process whose specific outcome is the progression of the gonadal mesoderm over time, from its formation to the mature structure. The gonadal mesoderm is the middle layer of the three primary germ layers of the embryo which will go on to form the gonads of the organism.
|
AMH,
ZFPM2
|
GO:0007507
|
BP
|
heart development
|
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
SH3PXD2B,
TBX1,
SHOX2,
MICAL2,
HEXIM1,
FGF19,
MBD3,
PDGFB,
TGFB1,
COL3A1,
RBP4,
RAF1,
ERBB2,
EDN1,
TH,
SPARC,
GLI2,
GLI3,
MTHFD1,
PSKH1,
PCNA,
BMP2,
TDGF1,
GYS1,
GJA1,
PAM,
EPOR,
TNNI3,
WT1,
ERBB3,
EDNRA,
ITGA3,
CAD,
LOX,
GNA11,
OXTR,
SRI,
ADM,
FBN1,
TGFBR1,
TGFBR2,
PPARG,
ID1,
ECE1,
CRKL,
NOTCH1,
TSC2,
GNAQ,
OXCT1,
PTEN,
FGF12,
TGFB2,
CXADR,
PRKDC,
PKD1,
MEF2A,
ID3,
MAP2K1,
TEK,
PPARD,
PTPN11,
MEF2C,
SOX4,
ZFP36L1,
PPARA,
EP300,
AP1B1,
AKAP13,
FOXC1,
MAP2K5,
GAB1,
PKD2,
ACVR2B,
CACNA1C,
COX17,
POU6F1,
NFATC4,
ERBB4,
RPS6KA2,
ARMC4,
JMJD6,
NEK8,
ADIPOR2,
BVES,
OSR1,
RB1CC1,
DNAH5,
PCSK5,
MED12,
DNAH11,
IFT74,
DRC1,
PKP2,
CITED2,
HOPX,
TCF25,
ADAM19,
BICC1,
ADAP2,
MKKS,
FLRT3,
CC2D2A,
TRPS1,
HDAC9,
HSPB11
|
GO:0007512
|
BP
|
adult heart development
|
The process whose specific outcome is the progression of the adult heart over time, from its formation to the mature structure.
|
BMP10,
GJA1,
ADRA1A,
MEF2D,
SCUBE1,
CHD7
|
GO:0007517
|
BP
|
muscle organ development
|
The process whose specific outcome is the progression of the muscle over time, from its formation to the mature structure. The muscle is an organ consisting of a tissue made up of various elongated cells that are specialized to contract and thus to produce movement and mechanical work.
|
CHD2,
MSTN,
TBX1,
USP2,
CRYAB,
IGF1,
DMD,
COL6A3,
XBP1,
CAPN3,
LAMA2,
SRI,
SOX6,
CENPF,
EMD,
ETV1,
FXR1,
SMTN,
EVC,
FOXK1,
FOXO4,
TAGLN,
MEF2A,
ID3,
CD164,
MEF2C,
EGR3,
FHL1,
MEF2D,
POU6F1,
TEAD4,
TWIST1,
ZFHX3,
SGCB,
CTF1,
KMT5B,
AEBP1,
EID2,
BVES,
SGCD,
SGCZ,
HBEGF,
TCF12,
CHODL,
ITGA11,
MKL2,
PAXBP1
|
GO:0007518
|
BP
|
myoblast fate determination
|
The cell fate determination process in which a cell becomes capable of differentiating autonomously into a myoblast regardless of its environment; upon determination, the cell fate cannot be reversed. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
|
IFRD1
|
GO:0007519
|
BP
|
skeletal muscle tissue development
|
The developmental sequence of events leading to the formation of adult skeletal muscle tissue. The main events are: the fusion of myoblasts to form myotubes that increase in size by further fusion to them of myoblasts, the formation of myofibrils within their cytoplasm and the establishment of functional neuromuscular junctions with motor neurons. At this stage they can be regarded as mature muscle fibers.
|
FOXP2,
CFLAR,
CCNT2,
SIN3B,
FLNB,
DCN,
MYL6B,
NR2F2,
HOXD10,
MYL6,
CDK5,
CAV1,
MEF2C,
EP300,
MAPK14,
BVES
|
GO:0007520
|
BP
|
myoblast fusion
|
A process in which non-proliferating myoblasts fuse to existing fibers or to myotubes to form new fibers. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
|
ADAM12,
MYH9,
GSK3B,
PLEKHO1,
PITX2
|
GO:0007521
|
BP
|
muscle cell fate determination
|
The cell fate determination process in which a cell becomes capable of differentiating autonomously into a muscle cell regardless of its environment; upon determination, the cell fate cannot be reversed.
|
MEF2C
|
GO:0007528
|
BP
|
neuromuscular junction development
|
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a neuromuscular junction.
|
MUSK,
NRDC,
ERBB2,
TNC,
CACNB3,
ANK3,
NTRK2,
ALS2,
PDZRN3
|